Invention Grant
- Patent Title: Antibodies specific for CD3 and uses thereof
-
Application No.: US16417859Application Date: 2019-05-21
-
Publication No.: US11434292B2Publication Date: 2022-09-06
- Inventor: James Reasoner Apgar , Fang Jin , Madan Katragadda , Divya Mathur , Lioudmila Gennadievna Tchistiakova
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Ye Hua; Bryan C. Zielinski
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; C07K16/30 ; C07K16/40 ; C07K16/46 ; A61K39/00
Abstract:
The present invention provides novel antibodies that specifically bind to CD3 and uses thereof. The invention also provides therapeutic and diagnostic methods utilizing the antibodies and antigen-binding fragments provided herein.
Public/Granted literature
- US20190382486A1 ANTIBODIES SPECIFIC FOR CD3 AND USES THEREOF Public/Granted day:2019-12-19
Information query
